Skip to content
About The Study
Introducing TEASE
ALK-001
FAQ
Participate
Contact
Resources
Stargardt Disease
Resources
Contact
Participants
Providers
TEASE Overview
Main Eligibility Criteria
Outcome Measures
About ALK-001
FAQ
About The Sponsor
Contact
References
About The Study
Introducing TEASE
ALK-001
FAQ
Participate
Contact
Resources
Stargardt Disease
Resources
Contact
Participants
Providers
TEASE Overview
Main Eligibility Criteria
Outcome Measures
About ALK-001
FAQ
About The Sponsor
Contact
References
About The Study
Introducing TEASE
ALK-001
FAQ
Participate
Contact
Resources
Stargardt Disease
Resources
Contact
Participants
Providers
TEASE Overview
Main Eligibility Criteria
Outcome Measures
About ALK-001
FAQ
About The Sponsor
Contact
References
Loading...
Clinical Study for the Treatment of Stargardt Disease Enrolling Participants in the USA.
Introducing TEASE, a Group of Clinical Studies Evaluating the Effects of ALK-001 on Stargardt Disease.
Welcome
Home
•
Welcome
Welcome
Zach Strecker
2018-11-15T16:46:49+00:00
